130 results on '"Weizel, Lilia"'
Search Results
2. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores
3. Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase
4. Integrating Siderophore Substructures in Thiol-Based Metallo-β-Lactamase Inhibitors
5. Studies on molecular properties prediction and histamine H3 receptor affinities of novel ligands with uracil-based motifs
6. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties
7. Designing a Small Fluorescent Inhibitor to Investigate Soluble Epoxide Hydrolase Engagement in Living Cells
8. N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-��-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa
9. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H 3/H 4 receptor ligands
10. N-Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases
11. Structure-Based Design of Dual Partial Peroxisome Proliferator-Activated Receptor γ Agonists/Soluble Epoxide Hydrolase Inhibitors
12. Cover Feature: Rh II ‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors (ChemMedChem 22/2021)
13. 2,4-Diaminopyrimidines as histamine H 4 receptor ligands—Scaffold optimization and pharmacological characterization
14. RhII-catalyzed de-symmetrization of ethane-1,2-dithiol and propane-1,3-dithiol yields metallo-β-lactamase inhibitors
15. Rh II ‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors
16. Second-Generation Dual FXR/sEH Modulators with Optimized Pharmacokinetics
17. Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice
18. Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator
19. N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa
20. Receptor-specific functional efficacies of alkyl imidazoles as dual histamine H3/H4 receptor ligands
21. Design, Synthesis, and Structure–Activity Relationship Studies of Dual Inhibitors of Soluble Epoxide Hydrolase and 5-Lipoxygenase
22. Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor g
23. Dual farnesoid X receptor/soluble epoxide hydrolase modulators derived from Zafirlukast
24. RhII‐Catalyzed De‐symmetrization of Ethane‐1,2‐dithiol and Propane‐1,3‐dithiol Yields Metallo‐β‐lactamase Inhibitors.
25. Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
26. Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
27. Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast.
28. Boosting Anti-Inflammatory Potency of Zafirlukast by Designed Polypharmacology
29. Synthesis, molecular properties estimations, and dual dopamine D2 and D3 receptor activities of benzothiazole-based ligands
30. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
31. N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosaElectronic supplementary information (ESI) available. See DOI: 10.1039/d1md00187f
32. Challenges in the Development of a Thiol-Based Broad-Spectrum Inhibitor for Metallo-β-Lactamases
33. Synthesis, Molecular Properties Estimations, and Dual Dopamine D2 and D3 Receptor Activities of Benzothiazole-Based Ligands
34. A Dual Modulator of Farnesoid X Receptor and Soluble Epoxide Hydrolase To Counter Nonalcoholic Steatohepatitis
35. Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness
36. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
37. Synthesis and evaluation of novel ligands for the histamine H4 receptor based on a pyrrolo[2,3-d]pyrimidine scaffold
38. Novel chalcone-based fluorescent human histamine H 3 receptor ligands as pharmacological tools
39. N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators
40. Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission Tomography
41. Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands
42. Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands
43. Corrigendum to “Benzylpiperidine variations on histamine H3 receptor ligands for improved drug-likeness” [Bioorg. Med. Chem. Lett. 24 (2014) 2236–2239]
44. Histamine H 3 and H 4 receptor affinity of branched 3-(1 H-imidazol-4-yl)propyl N-alkylcarbamates
45. Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists.
46. N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators.
47. Novel Chalcone-Based Fluorescent Human Histamine H3 Receptor Ligands as Pharmacological Tools
48. Synthesis of 1,2,3-Triazole Elements in Histamine H3 Receptor Ligands
49. First Metal-Containing Histamine H3 Receptor Ligands
50. Kojic Acid Derivatives as Histamine H3 Receptor Ligands
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.